Skip to content

Steven Kellner

  • Dr., MRCVS, FRMS, CertVOphthal
  • Chief Scientific Officer
  • Mesencell Biotech
  • 1h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 3CitationsNumber of citations received by Steven's publications. Updated daily.

Other IDs

Research interests

Diabetes T2cardiovascular diseasestrokemessenger RNAmicro RNAExosomesSecretomeParkinson diseaseAlzheimer diseasecartilageChondrocytesOsteoarthritisNeurologyTranslational medicineIn vitro researchMesenchymal stem cells

About

I am at the interface between Mesenchymal stem cell research and their application as translational medicine in the areas of osteoarthritis, Alzheimer Disease, Parkinson Disease, stroke, cardiovascular diseases, anti-morbidity and many more. In vitro research on cells has also meant finding new biomarkers for disease diagnoses and progression monitoring, i.e. a saliva biomarker for Alzheimers Disease

Publications (5)

  • Mesencell Biotech Activities extended version SK161030

    N/AReaders
    N/ACitations
  • Mesodermal geniodysplasia in the Siberian Husky

    • Kellner S
    N/AReaders
    3Citations
  • Preventing and Treating Diabetes type 2 with Neprilysin from adipose derived mesenchymal stem cells

    • James Kellner S
    • Ferchichi M
    N/AReaders
    N/ACitations
  • Treating Alzheimer's Disease with Neprilysin secreted by adipose derived mesenchymal stem cells?

    • Kellner S
    • Ferchichi M
    N/AReaders
    N/ACitations
  • UCH-L1 secreted by Mesenchymal stem cells as treatment for Alzheimer Disease Ubiquitin Protease System Effects of UCH-L1

    • James Kellner S
    • Rey T
    • Ferchichi M
    N/AReaders
    N/ACitations

Professional experience

Chief Scientific Officer

Mesencell Biotech

February 2016 - Present

Senior VP Research and Development

Med Cell Bahamas

January 2016 - Present

Founder and Head

Animaleye Clinic Switzerland

January 1992 - January 1999(7 years)

Head Med/DRA

Novartis Ophthalmics

January 1996 - January 1998(2 years)

Head Med/DRA

Ciba Vision Ophthalmics

January 1992 - January 1996(4 years)

Education

Stem Cells under GMP

Promocell

March 2009

Stem Cell Culture

Promocell

January 2009

CertVOphthal

Comparative Ophthalmology Unit Newmarket UK

January 1992 - January 1993(a year)

PhD

Universit of Zurich

January 1977 - January 1982(5 years)